Epilepsy and the Interictal State : (Record no. 47890)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 09211nam a22004813i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC1982915 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729123449.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2015 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781118951002 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9780470656235 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC1982915 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL1982915 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr11030106 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)880672328 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC372 -- .E655 2015eb |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | St Louis, Erik K. |
| 245 10 - TITLE STATEMENT | |
| Title | Epilepsy and the Interictal State : |
| Remainder of title | Co-Morbidities and Quality of Life. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Newark : |
| Name of producer, publisher, distributor, manufacturer | John Wiley & Sons, Incorporated, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2015. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2015. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (290 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Cover -- Title Page -- Copyright -- Contents -- List of contributors -- Preface -- Section I Quality of life and the interictal state in epilepsy -- Chapter 1 Quality of life in epilepsy: the key importance of the interictal state -- Introduction -- Tools for measuring QOL -- Ictal factors: seizure frequency and severity -- Interictal factors -- Conclusion -- References -- Chapter 2 Comorbidities in epilepsy: range and impact -- Introduction -- Psychosocial factors -- Social support -- Socioeconomic factors -- Somatic health issues -- Physician-patient interactions -- Health behavior and lifestyle factors -- AEDs and nutritional factors -- AEDs and comorbidity risk factors -- Conclusion -- References -- Chapter 3 Epilepsy, comorbidities, and consequences: implications for understanding and combating stigma -- Disclaimer -- Introduction -- Understanding stigma -- The burden of epilepsy stigma -- Epilepsy comorbidities and stigma -- Impact on QOL -- Combating stigma -- References -- Section II Cognition and epilepsy -- Chapter 4 Causes and types of cognitive domain impairments in epilepsy -- Impairment of consciousness in epilepsy -- Ictal cognitive impairments due to nonconvulsive status epilepticus -- Memory and dysexecutive impairments in epilepsy -- Attention deficit/hyperactivity disorder, disordered attention, and epilepsy -- Behavioral and developmental disorders in epilepsy -- Chapter 5 Cognitive effects of epilepsy therapies -- Introduction -- Cognitive effects of anticonvulsant medications -- Cognitive effects of surgical epilepsy treatments -- Treatment of cognitive deficits -- Conclusion -- References -- Chapter 6 Autism and epilepsy -- Introduction -- Autism: definition, subtypes, and etiology -- Autism in epilepsy -- Epilepsy and epileptiform EEG abnormalities in autism -- Conclusion -- References. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Chapter 7 Cognitive rehabilitation strategies in epilepsy -- Introduction -- Background -- Cognitive rehabilitation -- Assessment -- Primary cognitive complaints -- Other important factors -- Burden of normalcy -- Conclusion -- References -- Section III Adverse effects of epilepsy therapies -- Chapter 8 Adverse effects in epilepsy: recognition, measurement, and taxonomy -- Introduction -- Assessing antiepileptic medication adverse effects: a historical perspective -- Available instruments for assessment of seizure medication adverse effects -- Classification and taxonomy of adverse seizure medication effects -- Clinical utility of systematic screening for adverse effects -- References -- Chapter 9 Clinically important antiepileptic drug interactions and their influence on adverse effects in epilepsy -- Background -- Epidemiology -- Pathophysiology/etiology -- Diagnosis -- Practical aspects and treatment -- Pearls -- References -- Chapter 10 Minimizing the adverse effects of epilepsy therapies: principles and practice -- Introduction -- Adverse effects encountered during antiepileptic drug polytherapy -- Defining and identifying antiepileptic drug adverse effects -- General strategies for minimzing adverse effects -- Drug selection principles for minimizing adverse effects -- Practical approaches to minimizing adverse effects during antiepileptic drug polytherapy -- Conclusion -- References -- Chapter 11 Idiosyncratic adverse side effects of antiepileptic drugs: risk, prevention, and counseling -- Introduction -- Therapeutic considerations and idiosyncratic adverse drug reactions in infantile spasms treatment -- Therapeutic considerations and idiosyncratic adverse drug reactions in Lennox-Gastaut syndrome treatment -- Idiosyncratic allergic rash risk associated with antiepileptic drug therapies. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Idiosyncratic adverse effects associated with valproate and ethosuximide -- Idiosyncratic adverse effects associated with carbamazepine and oxcarbazepine -- Idiosyncratic adverse effects associated with topiramate and zonisamide -- Idiosyncratic adverse effects associated with rufinamide -- Idiosyncratic adverse effects associated with ezogabine -- Conclusion -- References -- Chapter 12 Antiepileptic drug therapy and fetal development -- Introduction -- The burden of epilepsy -- Epidemiology -- Pregnancy registers -- Polytherapy considerations -- Folate -- Results emerging from studies of AED exposure in pregnancy -- Teratogenicity of individual AEDs -- Cognitive developmental defects and AED exposure -- Conclusion -- Acknowledgments -- References -- Section IV Mood state, psychiatric comorbidity, and epilepsy -- Chapter 13 Mood state, anxiety, and psychosis in epilepsy -- Introduction -- Mood disorders and epilepsy -- Anxiety disorders and epilepsy -- Practical advice/pearls -- Psychoses and epilepsy -- Practical advice/pearls -- Conclusion -- References -- Chapter 14 The contribution of sleep and anxiety disorders to quality of life in people with epilepsy -- Introduction -- Anxiety and epilepsy -- Investigating the prevalence and nature of psychological distress in people with epilepsy -- What does this study add to the current picture? -- Conclusion -- Acknowledgements -- References -- Chapter 15 Epilepsy and personality -- Introduction -- Personality assessment in epilepsy -- TLE and Geschwind syndrome -- JME and Janz syndrome -- Studies of personality disorder in patients with mixed epilepsy -- Effect of epilepsy surgery -- Relationship between personality and QOL -- Conclusion -- References -- Chapter 16 Psychogenic attacks and epilepsy -- Introduction -- Epidemiology -- Pathophysiology -- Etiology -- Clinical features. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Diagnostic investigations -- Treatment -- Prognosis -- Follow-up -- The grey zone: driving and psychogenic attacks -- Conclusion -- References -- Section V General health and epilepsy -- Chapter 17 Obesity and epilepsy -- Introduction -- Epidemiology -- Pathophysiology -- Evaluation -- Treatment -- Prognosis -- References -- Chapter 18 Epilepsy in the elderly: vascular disease, the aging brain, and selection of appropriate therapies -- Introduction -- Epidemiology/etiologies/ pathophysiology -- Diagnostic evaluation -- Treatment -- Psychosocial implications of seizures in older people -- Practical advice and pearls -- References -- Chapter 19 Balance disorders and falls in epilepsy -- Introduction -- Epidemiology -- Pathophysiology -- Etiology -- Diagnosis/evaluation -- Management -- Conclusion -- References -- Chapter 20 Bone health in epilepsy -- Introduction -- Fracture rates -- Epidemiology -- Pathophysiology -- Diagnosis and evaluation -- Management -- Prognosis -- References -- Chapter 21 Sleep and epilepsy -- Introduction -- Pathophysiology -- The common sleep-related epilepsies -- Evaluation and differential diagnosis -- Treatment -- Conclusion -- References -- Chapter 22 Use of complementary and alternative medicine in epilepsy -- Introduction -- Use of CAM by people with epilepsy in Western countries -- Mind-body medicine -- Biologically-based practices -- Energy medicine -- Whole medical systems -- Conclusion -- References -- Chapter 23 Epilepsy and alcohol and substance abuse -- Introduction -- Alcohol -- Marijuana -- Cocaine -- Heroin -- Amphetamines, methamphetamine, and MDMA -- Benzodiazepines and barbiturates -- Drug use in persons with preexisting epilepsy -- Conclusion -- Practical advice and pearls -- References -- Chapter 24 Driving, employment, and related issues in epilepsy -- Introduction -- Driving -- Employment. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Recreation and socialization -- Conclusion -- References -- Index -- EULA. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Epilepsy -- Complications. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ficker, David M. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | O'Brien, Terence J. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | St Louis, Erik K. |
| Title | Epilepsy and the Interictal State |
| Place, publisher, and date of publication | Newark : John Wiley & Sons, Incorporated,c2015 |
| International Standard Book Number | 9780470656235 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=1982915">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=1982915</a> |
| Public note | Click to View |
No items available.